Immunotherapy After Surgery Provides Significant, Durable Benefit for High-Risk Bladder Patients
Newswise — New York, NY (February 17, 2023)—Immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo, according to clinical…
Read more Immunotherapy After Surgery Provides Significant, Durable Benefit for High-Risk Bladder Patients